Exchange: NASDAQ·Updated 07:43 PM EDT
CRVO logo

CRVO CervoMed Inc

$2.63
$0.03
(1.15%)
Today
Closed $2.63
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$39.31M
Vol94,999.00

About CRVO

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.
43

Bearish Sentiment

How do you feel about CRVO?

Advertisement|Remove ads.